Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia
Open Access
- 1 July 1992
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 70 (2), 135-140
- https://doi.org/10.1016/0002-9149(92)91264-5
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of Internal Medicine, 1988
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJama-Journal Of The American Medical Association, 1984
- Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a): A dose-response study of the effects of cholestyramine in hypercholesterolaemiaAtherosclerosis, 1982
- Effect of colestipol and clofibrate on plasma lipid and lipoproteins in Type IIa hyperlipoproteinemiaMetabolism, 1981
- Cholestyramine in type IIa hyperlipoproteinemia: Is low-dose treatment feasible?Atherosclerosis, 1981
- Bile sequestrant therapy alters the compositions of low-density and high-density lipoproteinsMetabolism, 1979
- Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortalityJournal of Chronic Diseases, 1978
- Cholestyramine in Type II HyperlipoproteinemiaAnnals of Internal Medicine, 1973
- Colestipol and Cholestyramine ResinJAMA, 1972
- Effects of colestipol (U-26,597A), a new bile acid sequestrant, on serum lipids in experimental animals and manAtherosclerosis, 1970